BioNexus Gene Lab Corporation (BGLC)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |||||
Total Assets | 7.8M | 8.74M | 8.19M | 7.9M | 11.47M | 11.4M | 11.16M | 11.14M |
Total Current Assets | 5.41M | 6.02M | 5.46M | 5.23M | 8.27M | 8.05M | 7.91M | 7.84M |
Cash and Equivalents | 478k | 612k | 407k | 297k | 4.71M | 2.62M | 2.49M | 2.2M |
Total Non-Current Assets | 3.83M | 4.23M | 4.21M | 4.07M | 4.69M | 4.87M | 4.73M | 4.65M |
Total Liabilities | 1.37M | 2.08M | 1.63M | 1.94M | 1.78M | 1.74M | 1.82M | 1.59M |
Total Current Liabilities | 1.34M | 2M | 1.56M | 1.88M | 1.64M | 1.63M | 1.72M | 1.4M |
Total Non-Current Liabilities | 39k | 71k | 67k | 59k | 134k | 111k | 101k | 194k |
Common Equity | 10.93M | 10.93M | 10.93M | 10.93M | 17.28M | 17.19M | 17.19M | 17.19M |
Retained Earnings | 1.31M | 1.16M | 1.09M | 828k | -1.78M | -1.84M | -1.95M | -1.75M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 10.12M | 9.57M | 8.74M | 11.4M |
Total Current Assets | 7.99M | 7.15M | 6.02M | 8.05M |
Cash and Equivalents | 700k | 579k | 612k | 2.62M |
Total Non-Current Assets | 6.66M | 7.18M | 6.67M | 9.66M |
Total Liabilities | 3.45M | 2.39M | 2.08M | 1.74M |
Total Current Liabilities | 3.37M | 2.33M | 2M | 1.63M |
Total Non-Current Liabilities | 114k | 91k | 71k | 111k |
Total Equity | 6.66M | 7.18M | 6.67M | 9.66M |
Common Equity | 10.78M | 10.78M | 10.93M | 17.19M |
Retained Earnings | 760k | 1.51M | 1.16M | -1.84M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.